Lantheus Holdings, Inc. (LNTH)
63.11
+2.29
(+3.77%)
USD |
NASDAQ |
Dec 11, 16:00
63.23
+0.12
(+0.19%)
After-Hours: 20:00
Lantheus Holdings Free Cash Flow: 411.69M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Cytokinetics, Inc. | -453.38M |
| Integra LifeSciences Holdings Corp. | -14.47M |
| Iovance Biotherapeutics, Inc. | -351.82M |
| Tandem Diabetes Care, Inc. | -25.12M |
| Day One Biopharmaceuticals, Inc. | -124.86M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 105.29M |
| Cash from Investing (Quarterly) | -319.47M |
| Cash from Financing (Quarterly) | -99.17M |
| Free Cash Flow Per Share (Quarterly) | 1.399 |
| Free Cash Flow to Equity (Quarterly) | 90.73M |
| Free Cash Flow to Firm (Quarterly) | 97.92M |
| Free Cash Flow Yield | 9.36% |